The TSRI biomedicalepidemic prevention sensor chip platform uses multi-functional integrated design, with advanced sensorchip design technologies integrating with AI systems, to achieve the goal of diversified epidemic prevention. The platform is open for R&D teams from industryuniversities to develop genetic engineering modification of specific virus typesestablish DNA identification technology, as well as to accelerate development cycle for emerging virus detectorsshorten the virus detection time.

Based on semiconductor manufacturing technology, TSRI uses the principle of DNA double-strand replication, the sample to be tested can be titrated into the hole structure through the arrayed hole structure. Through the micro-heater cycle temperature alternating process of 60℃ ~ 95℃, the biological nucleic acid synthesis that replicates specific DNA fragments in vitro to perform double-stranded replication of DNA. Through this technology. A large number of target genes can be produced in a short time which facilitates identification of specific DNA types through detection.

Industrial fields including start medical care, IoT, big data,disease management.

天使投資人、策略合作夥伴